HCmed Innovations Co., Ltd.
Rm.B, 10F., No.319, Sec.2, Dunhua S. Rd.Taipei City 10669
T: +886 2 2732 6596
E : email@example.com
HCmed Innovations focuses on the development of drug-device combination products for inhalation therapy. It develops and manufactures portable vibrating mesh nebulizers that offer a mature customization platform, aiming to enhance drug delivery. This technology enables efficient and reliable nebulization of different types of medication, ranging from small molecule synthetics to large molecule biologics, as either solutions, suspensions or even difficult-to-deliver high viscosity drugs.
By combining the strength of Taiwan’s world-class manufacturing industry and a well-established GMP certified manufacturing facility, HCmed’s products have received approval from multiple international health authorities, with some of them being launched in selected markets. Furthermore, the latest developments embrace the inclusion of more advanced features, such as breath actuation and connectivity in order to improve drug delivery efficacy and reinforce patience adherence.
HCmed is prompt to expand its combination development and continue to bring significant value to global pharmaceutical partners through a cost efficient and risk minimized pathway, pursuing the production of devices that improve treatment efficiency and patient compliance.
Portable Mesh Nebulizers
-The standard mesh nebulizer developed by HCmed allows to deliver different types of medication with an easy-to-use and effective system.
-Pulmogine Vibrating Mesh Nebulizer sets a novel customization platform for drug-device combination, broadening opportunities for development.
-HCmed’s newest smart breath-actuated mesh nebulizer combines the latest advancement in connectivity and drug delivery technology to provide a highly efficient inhalation treatment experience for combination products involving high value drugs.
-Smart cap prototype that operates with a mobile application to support patient adherence.
HCmed’s APSD laboratory is equipped with state-of-the-art measuring instruments that allow to conduct aerosol particle size distribution analysis.
A dynamic team of well-trained researchers meticulously works on the generation of reliable data to examine aerosol characteristics and to continue improving HCmed’s devices with different types of medication, including those provided by pharmaceutical partners.
-Spraytec by Malvern (Laser Diffraction Particle Sizer)
-Breathing Simulator (BRS2100) by Copley
-UV-Visible Spectrophotometer (Lambda 365) by Perkin Elmer
-Next Generation Pharmaceutical Impactor (NGI)
In order to foster innovation, HCmed foments intellectual property protection. HCmed’s intellectual property records include 62 patents from different development aspects, such as mesh module, breathing sensors, cleaning methods, and wireless authentication systems.
Posted Date: 12/7/2020
This record has been viewed 3883 times.